Single-point mutations of the M protein of a measles virus variant obtained from a patient with subacute sclerosing panencephalitis critically affect solubility and subcellular localization of the M protein and cell-free virus production

Microbes and Infection

Volumn 11, Issue 4, 2009, Pages 467-475

  Jiang, Da Peng ^a   Ide, Yoshi Hiro ^a   Nagano Fujii, Motoko ^a   Shoji, Ikuo ^a   Hotta, Hak ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Matrix protein; Measles virus; Solubility; SSPE virus; Subacute sclerosing panencephalitis; Subcellular localization; Virion release

Indexed keywords

M PROTEIN; TRITON X 100; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CELLULAR DISTRIBUTION; CHO CELL; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION SYSTEM; GENOTYPE; HUMAN; MEASLES VIRUS; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROGENY; PROTEIN LOCALIZATION; SOLUBILITY; SUBACUTE SCLEROSING PANENCEPHALITIS; VERO CELL; VIRUS REPLICATION; VIRUS STRAIN; VIRUS VIRULENCE;

AMINO ACID SUBSTITUTION; ANIMALS; CELL NUCLEUS; CERCOPITHECUS AETHIOPS; CYTOPLASM; HUMANS; MEASLES VIRUS; MUTATION, MISSENSE; POINT MUTATION; SOLUBILITY; SUBACUTE SCLEROSING PANENCEPHALITIS; VERO CELLS; VIRAL PROTEINS; VIRUS REPLICATION;

MEASLES VIRUS;

EID: 64549126875     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2009.01.009     Document Type: Article

References (30)

1. Okuno Y., Nakao T., Ishida N., Konno T., Mizutani H., Fukuyama Y., Sato T., Isomura S., Ueda S., and Kitamura I. Incidence of subacute sclerosing panencephalitis following measles and measles vaccination in Japan. Int. J. Epidemiol. 18 (1989) 684-689
2. Anlar B., Aydin O.F., Guven A., Sonmez F.M., Kose G., and Herguner O. Retrospective evaluation of interferon-beta treatment in subacute sclerosing panencephalitis. Clin. Ther. 26 (2004) 1890-1894
3. International Consortium on Subacute Sclerosing Panencephalitis. Gascon G.G. Randomized treatment study of inosiplex versus combined inosiplex and intraventricular interferon-alpha in subacute sclerosing panencephalitis (SSPE): international multicenter study. J. Child Neurol. 18 (2003) 819-827
4. Hosoya M., Mori S., Tomoda A., Mori K., Sawaishi Y., Kimura H., Shigeta S., and Suzuki H. Pharmacokinetics and effects of ribavirin following intraventricular administration for treatment of subacute sclerosing panencephalitis. Antimicrob. Agents Chemother. 48 (2004) 4631-4635
5. Otaki M., Sada K., Kadoya H., Nagano-Fujii M., and Hotta H. Inhibition of measles virus and subacute sclerosing panencephalitis virus by RNA interference. Antiviral Res. 70 (2006) 105-111
6. Otaki M., Jiang D.P., Sasayama P.M., Nagano-Fujii M., and Hotta H. Generation of recombinant adenovirus expressing siRNA against the L mRNA of measles virus and subacute sclerosing panencephalitis virus. Microbiol. Immunol. 51 (2007) 985-991
7. Griffin D.E. Measles virus. In: Knipe D.M., and Howley P.M. (Eds). Fields Virology. 5th ed. (2007), Lippincott Williams and Wilkins Co., Philadelphia, PA 1551-1585
8. Cattaneo R., Schmid A., Eschle D., Baczko K., ter Meulen V., and Billeter M.A. Biased hypermutation and other genetic changes in defective measles viruses in human brain infections. Cell 55 (1988) 255-265
9. Cattaneo R., and Billeter M.A. Mutations and A/I hypermutations in measles virus persistent infections. Curr. Top. Microbiol. Immunol. 176 (1992) 63-74
10. Rima B.K., and Duprex W.P. Molecular mechanisms of measles virus persistence. Virus Res. 111 (2005) 132-147
11. Hirano A., Ayata M., Wang A.H., and Wong T.C. Functional analysis of matrix proteins expressed from cloned genes of measles virus variants that cause subacute sclerosing panencephalitis reveals a common defect in nucleocapsid binding. J. Virol. 67 (1993) 1848-1853
12. Hirano A., Wang A.H., Gombart A.F., and Wong T.C. The matrix proteins of neurovirulent subacute sclerosing panencephalitis virus and its acute measles virus progenitor are functionally different. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 8745-8749
13. Patterson J.B., Cornu T.I., Redwine J., Dales S., Lewicki H., Holz A., Thomas D., Billeter M.A., and Oldstone M.B. Evidence that the hypermutated M protein of a subacute sclerosing panencephalitis measles virus actively contributes to the chronic progressive CNS disease. Virology 291 (2001) 215-225
14. Ning X., Ayata M., Kimura M., Komase K., Furukawa K., Seto T., Ito N., Shingai M., Matsunaga I., Yamano T., and Ogura H. Alterations and diversity in the cytoplasmic tail of the fusion protein of subacute sclerosing panencephalitis virus strains isolated in Osaka, Japan. Virus Res. 86 (2002) 123-131
15. Ayata M., Hayashi K., Seto T., Murata R., and Ogura H. The matrix gene expression of subacute sclerosing panencephalitis (SSPE) virus (Osaka-1 strain): a comparison of two sibling viruses isolated from different lobes of an SSPE brain. Microbiol. Immunol. 42 (1998) 773-780
16. Hotta H., Nihei K., Abe Y., Kato S., Jiang D.P., Nagano-Fujii M., and Sada K. Full-length sequence analysis of subacute sclerosing panencephalitis (SSPE) virus, a mutant of measles virus, isolated from brain tissues of a patient shortly after onset of SSPE. Microbiol. Immunol. 50 (2006) 525-534
17. Peebles M.E. Paramyxovirus M proteins, pulling it all together and taking it on the road. In: Kingsbury D.W. (Ed). The Paramyxoviruses (1991), Plenum Press, New York 427-456
18. Hall W.W., Lamb R.A., and Choppin P.W. Measles and subacute sclerosing panencephalitis virus proteins: lack of antibodies to the M protein in patients with subacute sclerosing panencephalitis. Proc. Natl. Acad. Sci. U. S. A. 76 (1979) 2047-2051
19. Wechsler S.L., Weiner H.L., and Fields B.N. Immune response in subacute sclerosing panencephalitis: reduced antibody response to the matrix protein of measles virus. J. Immunol. 123 (1979) 884-889
20. Ono N., Tatsuo H., Hidaka Y., Aoki T., Minagawa H., and Yanagi Y. Measles viruses on throat swabs from measles patients use signaling lymphocytic activation molecule (CDw150) but not CD46 as a cellular receptor. J. Virol. 75 (2001) 4399-4401
21. Itoh M., Okuno Y., and Hotta H. Comparative analysis of titers of antibody against measles virus in sera of vaccinated and naturally infected Japanese individuals of different age groups. J. Clin. Microbiol. 40 (2002) 1733-1738
22. Katayama Y., Shibahara K., Kohama T., Homma M., and Hotta H. Molecular epidemiology and changing distribution of genotypes of measles virus field strains in Japan. J. Clin. Microbiol. 35 (1997) 2651-2653
23. Kobune F., Sakata H., and Sugiura A. Marmoset lymphoblastoid cells as a sensitive host for isolation of measles virus. J. Virol. 64 (1990) 700-705
24. Shibahara K., Hotta H., Katayama Y., and Homma M. Increased binding activity of measles virus to monkey red blood cells after long-term passage in Vero cell cultures. J. Gen. Virol. 75 (1994) 3511-3516
25. Takeda M., Sakaguchi T., Li Y., Kobune F., Kato A., and Nagai Y. The genome nucleotide sequence of a contemporary wild strain of measles virus and its comparison with the classical Edmonston strain genome. Virology 256 (1999) 340-350
26. Takeda M., Takeuchi K., Miyajima N., Kobune F., Ami Y., Nagata N., Suzaki Y., Nagai Y., and Tashiro M. Recovery of pathogenic measles virus from cloned cDNA. J. Virol. 74 (2000) 6643-6647
27. Takimoto T., and Portner A. Molecular mechanism of paramyxovirus budding. Virus Res. 106 (2004) 133-145
28. Cathomen T., Mrkic B., Spehner D., Drillien R., Naef R., Pavlovic J., Aguzzi A., Billeter M.A., and Cattaneo R. A matrix-less measles virus is infectious and elicits extensive cell fusion: consequences for propagation in the brain. EMBO J. 17 (1998) 3899-3908
29. Moll M., Klenk H.D., Herrler G., and Maisner A. A single amino acid change in the cytoplasmic domains of measles virus glycoproteins H and F alters targeting, endocytosis, and cell fusion in polarized Madin-Darby canine kidney cells. J. Biol. Chem. 276 (2001) 17887-17894
30. Runkler N., Pohl C., Schneider-Schaulies S., Klenk H.D., and Maisner A. Measles virus nucleocapsid transport to the plasma membrane requires stable expression and surface accumulation of the viral matrix protein. Cell. Microbiol. 9 (2007) 1203-1214